Immunovative Therapies is a clinical-stage biopharmaceutical company specializing in the translation of proven immune mechanisms into immunotherapy products and protocols for the treatment of cancer and infectious diseases.The company's patented Mirror Effect technology provides an immunological platform for the development of drugs that elicit the same anti-tumor and anti-HIV effects as bone marrow/stem cell transplant procedures while eliminating the side effects and need for a tissue-matched donor.Immunovative has two products in clinical development: AlloStim, a bioengineered living cell allograft, and chaperone-rich cell lysate (CRCL), a patient-specific heat shock protein vaccine.

AlloStim uses a tumor cryoablation method to create an in-situ cancer vaccine called CryoVax and combines this with CRCL to create a personalized cancer vaccine called AlloVax.